Biocryst reports inducement grants under nasdaq listing rule 5635(c)(4)

Research triangle park, n.c., sept. 04, 2024 (globe newswire) -- biocryst pharmaceuticals, inc. (nasdaq: bcrx) today announced that the compensation committee of biocryst's board of directors granted nine newly-hired employees stock options to purchase an aggregate of 28,400 shares, and restricted stock units (rsus) covering an aggregate of 20,025 shares, of biocryst common stock. the options and rsus were granted as of august 30, 2024, as inducements material to each employee entering into employment with biocryst. the options and rsus were granted in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking